#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodegenerative disorder Immune thrombocytopenia Craniopharyngioma Pleural mesothelioma malignant Plasma cell myeloma refractory Anti-myelin-associated glycoprotein antibodies positive Dedifferentiated liposarcoma Uterine leiomyosarcoma Hypergammaglobulinaemia benign monoclonal Cutaneous T-cell lymphoma refractory Haemophagocytic lymphohistiocytosis Leukocyte adhesion deficiency Indolent systemic mastocytosis Rheumatoid arthritis Methylmalonic acidaemia More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing Sarcoidosis – Diagnostics SAPHO syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Treatment Mast cell activation syndrome – Trials in Disease Uterine leiomyosarcoma – Life with Disease Glycogen storage disease type II – Diagnostics Glomerulonephritis membranoproliferative Advanced systemic mastocytosis – Treatment Alport’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMODIAQUINE Pervi-Neo Tertomotide GSK3862995B Nystatin Amylase Ucp4 Tapentadol Hydrochloride Orlistat Digoxin Immune Fab (Ovine) Vusolimogene Oderparepvec HSP-CAR30 [18F]Fapi-74 Atezolizumab Trientine Dihydrochloride Sulodexide Valine Dexlansoprazole Dydrogesterone Linagliptin More therapies…

    Learn about Your Condition

    EGFR gene mutation Glanzmann's disease Haematological infection Acquired ATTR amyloidosis Chronic kidney disease Anal cancer Deafness bilateral Supranuclear palsy Atrial fibrillation Uveal melanoma Liver transplant rejection Chondrocalcinosis Pneumonia bacterial Lymphocytic lymphoma Vertebrobasilar stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Colestyramine
    France

  • Study on Cisplatin, Gemcitabine, and Paclitaxel Albumin-Bound for Patients with Resectable Biliary Tract Cancer at High Risk of Recurrence

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Gemcitabine Hydrochloride
    Italy

  • Study on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia France +6

  • Study on Desflurane, Sevoflurane, and Propofol for Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Postoperative delirium
    Investigated Drugs:
    • Desflurane
    • Sevoflurane
    • Propofol
    Austria

  • Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland Romania Spain

  • Study on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Deutivacaftor
    • Vanzacaftor
    • Tezacaftor
    Belgium France Germany The Netherlands Sweden
Previous Page
1 … 589 590 591 592 593 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!